ARPICCO, Silvia Maria Angela
 Distribuzione geografica
Continente #
NA - Nord America 6.758
EU - Europa 4.982
AS - Asia 1.957
SA - Sud America 41
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 18
AF - Africa 17
Totale 13.796
Nazione #
US - Stati Uniti d'America 6.479
IT - Italia 1.355
CN - Cina 1.172
IE - Irlanda 751
SE - Svezia 556
DE - Germania 539
FR - Francia 406
FI - Finlandia 362
GB - Regno Unito 307
KR - Corea 291
UA - Ucraina 265
CA - Canada 261
PL - Polonia 137
JP - Giappone 120
AT - Austria 114
VN - Vietnam 109
IN - India 90
ES - Italia 53
RO - Romania 32
TW - Taiwan 32
SG - Singapore 30
EU - Europa 22
IR - Iran 21
NL - Olanda 21
BR - Brasile 20
HK - Hong Kong 20
RU - Federazione Russa 19
TR - Turchia 19
BE - Belgio 17
MX - Messico 17
AU - Australia 13
CH - Svizzera 11
ID - Indonesia 10
IL - Israele 8
PT - Portogallo 8
TH - Thailandia 8
CO - Colombia 7
MY - Malesia 7
CL - Cile 6
GR - Grecia 6
UZ - Uzbekistan 6
NG - Nigeria 5
NZ - Nuova Zelanda 5
AR - Argentina 4
CZ - Repubblica Ceca 4
JO - Giordania 4
RS - Serbia 4
SN - Senegal 4
ZA - Sudafrica 4
LT - Lituania 3
PE - Perù 3
SA - Arabia Saudita 3
BG - Bulgaria 2
CY - Cipro 2
DK - Danimarca 2
EG - Egitto 2
HU - Ungheria 2
PK - Pakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
EC - Ecuador 1
EE - Estonia 1
HR - Croazia 1
IQ - Iraq 1
IS - Islanda 1
LU - Lussemburgo 1
MD - Moldavia 1
MU - Mauritius 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
QA - Qatar 1
ZM - Zambia 1
Totale 13.796
Città #
Chandler 781
Dublin 739
Beijing 571
Fairfield 411
Ann Arbor 406
Torino 395
Houston 393
Ashburn 289
Jacksonville 269
Medford 225
Wilmington 221
Princeton 216
Villeurbanne 209
Woodbridge 206
Montréal 199
Nyköping 178
Seattle 164
Dearborn 163
Cambridge 128
Munich 127
Warsaw 123
Vienna 111
Mcallen 107
Boston 94
Pisa 94
Redwood City 94
Dong Ket 63
Milan 61
Boardman 60
Shanghai 59
Fremont 50
Turin 50
Rome 49
Nanjing 46
Hangzhou 41
Norwalk 34
Verona 34
San Diego 31
Guangzhou 30
Hefei 30
New York 28
Shenyang 25
Jinan 24
Taipei 24
Zhengzhou 24
Toronto 22
Tokyo 21
Xian 20
Paris 19
Kunming 18
Chengdu 16
Falls Church 16
Helsinki 16
Erlangen 15
Lappeenranta 15
Washington 15
Pune 14
Brussels 13
Fuzhou 13
Wuhan 13
Hebei 12
Palermo 12
Singapore 12
Upper Marlboro 12
Düsseldorf 11
Nanchang 11
Ottawa 11
Phoenix 11
Bologna 10
Harbin 10
London 10
Seoul 10
Ningbo 9
Piemonte 9
Vancouver 9
Dallas 8
Detroit 8
Lachine 8
Mumbai 8
Parma 8
Silver Spring 8
Berlin 7
Grafing 7
Mondavio 7
Mountain View 7
Padova 7
Philadelphia 7
Recife 7
San Mateo 7
Siena 7
Valencia 7
Buffalo 6
Chennai 6
Chicago 6
Concepción 6
Granada 6
Hong Kong 6
Istanbul 6
Polska 6
Baotou 5
Totale 8.252
Nome #
Hyaluronated mesoporous silica nanoparticles for active targeting: influence of conjugation method and hyaluronic acid molecular weight on the nanovector properties 397
Cationic liposomes contaiing a DOPE-hyaluronic acid conjugate for gene delivery 371
Intravesical thermo-chemotherapy based on conductive heat: a first pharmacokinetic study with Mitomycin C in superficial transitional cell carcinoma patients 318
Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts 264
Validation of a simple and economic HPLC-UV method for the simultaneous determination of vancomycin, meropenem, piperacillin and tazobactam in plasma samples 251
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors 246
Caratterizzazione di nanoparticelle di polialchilcianoacrilato coniugate con l’acido folico 231
Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate-copper complex loaded into hyaluronic acid decorated liposomes 176
Pentamidine-Loaded Lipid and Polymer Nanocarriers as Tunable Anticancer Drug Delivery Systems 172
Hyaluronic acid-conjugated lipoplexes for targeted delivery of siRNA in a murine metastatic lung cancer model. 166
Liposomal Nitrooxy-Doxorubicin: One Step over Caelyx in Drug-Resistant Human Cancer Cells 166
Coencapsulation of disulfiram and doxorubicin in liposomes strongly reverses multidrug resistance in breast cancer cells 161
Hyaluronan-decorated liposomes as drug delivery systems for cutaneous administration 154
Cell uptake and intracellular fate of phospholipidic manganese-based nanoparticles 153
Chemical and microbiological stability, anticoagulant efficacy and toxicity of 35 and 90 mM trisodium citrate solutions stored in plastic syringes 152
Preparazione e caratterizzazione di liposomi convenzionali ed a lunga circolazione contenenti taxani 148
Advances in anticancer antibody-drug conjugates and immunotoxins. 147
Polysaccharide-coated liposomes by post-insertion of a hyaluronan-lipid conjugate 145
Recent studies on the delivery of hydrophilic drugs in nanoparticulate systems. 145
Preparation and characterization of novel poly(ethylene glycol) paclitaxel derivatives. 143
Ruthenium polypyridyl squalene derivative: a novel self-assembling lipophilic probe for cellular imaging 142
Hyaluronic acid-bearing lipoplexes: physico-chemical characterization and in vitro targeting of the CD44 receptor 140
Peptide conjugation: before or after nanoparticle formation? 134
Synthesis of defined oligohyaluronates-decorated liposomes and interaction with lung cancer cells 129
Rationally designed hyaluronic acid-based nano-complexes for pentamidine delivery 123
Hyaluronic acid-coated liposomes for active targeting of gemcitabine. 121
Targeted Cancer Therapy: The Roles Played by Antibody-Drug and Antibody-Toxin Conjugates 115
Nonpolymeric nanoassemblies for ocular administration of acyclovir: pharmacokinetic evaluation in rabbits 112
SWCNT-porphyrin nano-hybrids selectively activated by ultrasound: an interesting model for sonodynamic applications 112
Uptake and intracellular distribution of different types of nanoparticles in primary human myoblasts and myotubes 109
The role of conjugation processes and crosslinking agent in the preparation of molecular/particulate conjugates: a review 105
Supramolecular organization and siRNA binding of hyaluronic acid-coated lipoplexes for targeted delivery to the CD44 receptor. 104
Hyaluronic Acid Conjugates as Vectors for the Active Targeting of Drugs, Genes and Nanocomposites in Cancer Treatment 104
Lipid-Based Nanovectors for Targeting of CD44-Overexpressing Tumor Cells 101
Preparation, characterization and properties in vitro and in vivo of a paclitaxel-albumin conjugate 98
Strategies to Obtain Encapsulation and Controlled Release of Pentamidine in Mesoporous Silica Nanoparticles 94
Heteronanoparticles by self-Assembly of Doxorubicin and Cyclopamine Conjugates 94
Evaluation of the bactericidal activity of a hyaluronic acid-vehicled clarithromycin antibiotic mixture by confocal laser scanning microscopy 94
A first pharmacokinetic study of mitomycin C intravesical thermo-chemotherapy for the treatment of superficial transitional cell carcinoma, "Beyond the Abstract," by Paola Milla, et al. 90
Immunotossine di nuova generazione: coniugati anticorpo monoclonale-tossina caratterizzati da elevata stabilità plasmatica e specifica attività antitumorale. 88
Vinyl sulfide derivatives of truncated oxidosqualene as selective inhibitors of oxidosqualene and squalene-hopene cyclases 87
Preparazione e caratterizzazione di liposomi convenzionali e a lunga circolazione contenenti taxani 86
Anticancer prodrugs: an overview of major strategies and recent developments. 85
Biological characterization of folic acid-conjugated poly(H(2)NPEGCA-co-HDCA) nanoparticles in cellular models 84
Effects of the Molecular Weight of Hyaluronic Acid in a Carbon Nanotube Drug Delivery Conjugate 84
Veicolazione del paclitaxel e di sue prodrugs idrofile in liposomi ed immunoliposomi. 81
Delivery of gemcitabine prodrugs employing mesoporous silica nanoparticles 80
29-methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase. 79
Evaluation of the targeting ability of folate containing liposomal nitrooxy-doxorubicin. 79
Hyaluronic acid-decorated liposomes as innovative targeted delivery system for lung fibrotic cells 79
Hyaluronic acid for anticancer drug and nucleic acid delivery 78
Characterisation of folic acid-nanoparticles conjugates for tumoral targeting 77
Veicolazione di taxani in liposomi convenzionali ed a lunga circolazione 76
New DSPE-PEG-Folate conjugates for liposomal drug targeting 76
Disulfiram liposomiale: una nuova strategia contro l’adenocarcinoma duttale del pancreas. 76
Biological characterisation of folic acid-conjugated nanoparticles in cellular models 75
A sequence-dependent combination of docetaxel and vinorelbine: pharmacokinetic interactions 74
Synthesis, characterization and biological activity of new cationic lipids active for gene transfection. 73
Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain 73
PREPARATION AND CHARACTERIZATION OF LIPOSOMES CONTAINING A NEW ANTHRACYCLINE DERIVATIVE 71
Efficacy of a topical lotion containing lactoferricin, glycerophosphoinositol lysine and verbascoside for external otitis due to atopic dermatitis 69
Design of folic acid-conjugated nanoparticles for drug targeting 68
Synthesis, characterization and biological evaluation of new PEG-paclitaxel derivatives. 68
Nonpolymeric nanoparticles for ocular administration of acyclovir 68
Cationic liposomes contaiing a DOPE-hyaluronate conjugate for gene delivery 68
Veicolazione ed attività antitumorale di derivati della 5-fluorouridina mediante anticorpi monoclonali 68
MRP5 nitration by NO-releasing gemcitabine encapsulated in liposomes confers sensitivity in chemoresistant pancreatic adenocarcinoma cells 68
Hyaluronic acid-modified liposomes: preparation and preliminary biological characterization 67
Use of soluble paclitaxel prodrugs for novel liposomal formulations. 66
Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity 66
Exploiting lipid and polymer nanocarriers to improve the anticancer sonodynamic activity of chlorophyll 66
Chemioembolizzazione intraarteriosa con una nuova formulazione paclitaxel-lipiodol nel trattamento di neoplasie epatiche. 64
Hyaluronan liposomes for antitumor drug delivery 63
Incorporation and release of gemcitabine prodrug in mesoporous silica nanoparticles 63
Synthesis, characterization and transfection activity of new saturated and unsaturated cationic lipids 61
Antitumoral activity of PEG-gemcitabine prodrugs targeted by folic acid 61
Transfezione genica con vettori non virali 61
Uptake and intracellular fate of biocompatible nanocarriers in cycling and noncycling cells 61
ANTITUMORAL ACTIVITY OF LIPOSOMES AND IMMUNOLIPOSOMES CONTAINING 5-FLUOROURIDINE PRODRUGS 61
Liposomes based on a new cationic lipid: delivery of a decoy oligonucleotide against NF-kB transcription factor 60
Preparation and characterization of novel PEG-paclitaxel derivatives 60
Detection of flourescent nanoparticles containing squalene-cyclopamine and squalene-paclitaxel 60
Fluorescence and electron microscopy to visualize the intracellular fate of nanoparticles for drug delivery 60
Incorporation and release of gemcitabine prodrug in mesoporous silica nanoparticles 59
Fluorescence and electron microscopy to visualize the intracellular fate of nanoparticles for drug delivery 58
INCAPSULATED NO-GEMCITABINE: GASEOUS SOLUTION FOR MDR PANCREATIC CANCER 58
Developing actively targeted nanoparticles to fight cancer: Focus on italian research 58
Identification of biological feature and of alternative therapeutic strategies for pancreatic cancer stem cells lines in 3D culture models. 58
Characterisation of folic acid-conjugated nanoparticles for tumoral targeting 57
Veicolazione del paclitaxel mediante albumina umana. Ottimizzazione delle caratteristiche farmacocinetiche mediante mascheramento con PEG. 57
Manganese-containing nanoparticles as potential MRI contrast agent: an in vitro study. 57
Single-step purification of immunotoxins containing a high-anionic charge ribosome-inactivating protein clavin by carboxymethyl high-performance membrane chromatography 56
Cyanoacrylate nanospheres and nanocapsules containing lipophilic prodrugs of gemcitabine 56
Incorporation of lipophilic gemcitabine prodrugs in liposomes 56
Targeting of 5-florouracil and derivatives in the treatment of human colorectal adenocarcinomas. 56
SWCNT and graphene as meso-porphyrins delivery agents: synthetic approaches for Sono-Dynamic applications 56
Cationic liposomes contaiing a DOPE-hyaluronic acid conjugate for gene delivery 55
In vitro stability of lipophilic gemcitabine prodrugs 55
Preparation and characterisation of taxane containing liposomes. 55
Caratterizzazione e studio dell’attività di una nuova classe di lipidi cationici. 54
Totale 10.326
Categoria #
all - tutte 38.777
article - articoli 0
book - libri 0
conference - conferenze 15.379
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.156


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019527 0 0 0 0 0 0 0 0 0 0 337 190
2019/20202.161 151 128 168 223 134 350 246 143 235 188 123 72
2020/20211.942 236 99 118 77 147 116 229 114 227 188 173 218
2021/20222.221 87 85 89 153 121 78 183 157 85 106 602 475
2022/20232.737 270 151 55 247 222 725 311 169 283 77 150 77
2023/20241.028 138 238 83 72 96 137 57 77 15 114 1 0
Totale 14.384